Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

eNOS deficiency predisposes podocytes to injury in diabetes.

Yuen DA, Stead BE, Zhang Y, White KE, Kabir MG, Thai K, Advani SL, Connelly KA, Takano T, Zhu L, Cox AJ, Kelly DJ, Gibson IW, Takahashi T, Harris RC, Advani A.

J Am Soc Nephrol. 2012 Nov;23(11):1810-23. doi: 10.1681/ASN.2011121170.

2.

Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression.

Miyazawa T, Zeng F, Wang S, Fan X, Cheng H, Yang H, Bian A, Fogo AB, Harris RC.

Kidney Int. 2013 Dec;84(6):1176-88. doi: 10.1038/ki.2013.214.

3.

Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.

Kanetsuna Y, Takahashi K, Nagata M, Gannon MA, Breyer MD, Harris RC, Takahashi T.

Am J Pathol. 2007 May;170(5):1473-84.

4.

Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.

Advani A, Wiggins KJ, Cox AJ, Zhang Y, Gilbert RE, Kelly DJ.

Nephrology (Carlton). 2011 Aug;16(6):573-81. doi: 10.1111/j.1440-1797.2011.01451.x.

PMID:
21342330
5.

Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse.

Tanabe K, Lanaspa MA, Kitagawa W, Rivard CJ, Miyazaki M, Klawitter J, Schreiner GF, Saleem MA, Mathieson PW, Makino H, Johnson RJ, Nakagawa T.

Am J Physiol Renal Physiol. 2012 May 1;302(9):F1151-60. doi: 10.1152/ajprenal.00596.2011.

6.

Reduced Krüppel-like factor 2 expression may aggravate the endothelial injury of diabetic nephropathy.

Zhong F, Chen H, Wei C, Zhang W, Li Z, Jain MK, Chuang PY, Chen H, Wang Y, Mallipattu SK, He JC.

Kidney Int. 2015 Feb;87(2):382-95. doi: 10.1038/ki.2014.286.

7.

Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.

Jha JC, Thallas-Bonke V, Banal C, Gray SP, Chow BS, Ramm G, Quaggin SE, Cooper ME, Schmidt HH, Jandeleit-Dahm KA.

Diabetologia. 2016 Feb;59(2):379-89. doi: 10.1007/s00125-015-3796-0.

PMID:
26508318
8.

Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.

Zhang M, Liu M, Xiong M, Gong J, Tan X.

J Ethnopharmacol. 2012 May 7;141(1):111-8. doi: 10.1016/j.jep.2012.02.007.

PMID:
22353431
9.

Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.

Barutta F, Grimaldi S, Franco I, Bellini S, Gambino R, Pinach S, Corbelli A, Bruno G, Rastaldi MP, Aveta T, Hirsch E, Di Marzo V, Gruden G.

Kidney Int. 2014 Nov;86(5):979-90. doi: 10.1038/ki.2014.165.

PMID:
24827776
10.

Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy.

Sun YB, Qu X, Zhang X, Caruana G, Bertram JF, Li J.

PLoS One. 2013;8(1):e55027. doi: 10.1371/journal.pone.0055027.

11.

Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.

Sonneveld R, van der Vlag J, Baltissen MP, Verkaart SA, Wetzels JF, Berden JH, Hoenderop JG, Nijenhuis T.

Am J Pathol. 2014 Jun;184(6):1715-26. doi: 10.1016/j.ajpath.2014.02.008.

PMID:
24731445
12.

Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist.

Zhang Y, Deb DK, Kong J, Ning G, Wang Y, Li G, Chen Y, Zhang Z, Strugnell S, Sabbagh Y, Arbeeny C, Li YC.

Am J Physiol Renal Physiol. 2009 Sep;297(3):F791-801. doi: 10.1152/ajprenal.00247.2009.

13.

Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.

Mima A, Kitada M, Geraldes P, Li Q, Matsumoto M, Mizutani K, Qi W, Li C, Leitges M, Rask-Madsen C, King GL.

FASEB J. 2012 Jul;26(7):2963-74. doi: 10.1096/fj.11-202994.

14.

Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.

Fang L, Radovits T, Szabó G, Mózes MM, Rosivall L, Kökény G.

Nephrol Dial Transplant. 2013 Jul;28(7):1751-61. doi: 10.1093/ndt/gfs391.

PMID:
23203993
15.

Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes.

Kim DK, Nam BY, Li JJ, Park JT, Lee SH, Kim DH, Kim JY, Kang HY, Han SH, Yoo TH, Han DS, Kang SW.

Diabetologia. 2012 Apr;55(4):1205-17. doi: 10.1007/s00125-012-2467-7.

PMID:
22311416
16.

ENOS deficiency causes podocyte injury with mitochondrial abnormality.

Ueda S, Ozawa S, Mori K, Asanuma K, Yanagita M, Uchida S, Nakagawa T.

Free Radic Biol Med. 2015 Oct;87:181-92. doi: 10.1016/j.freeradbiomed.2015.06.028.

PMID:
26119782
17.

Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.

Li SY, Huang PH, Tarng DC, Lin TP, Yang WC, Chang YH, Yang AH, Lin CC, Yang MH, Chen JW, Schmid-Schönbein GW, Chien S, Chu PH, Lin SJ.

J Am Soc Nephrol. 2015 Dec;26(12):3072-84. doi: 10.1681/ASN.2014100989.

18.

Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.

Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B.

J Am Soc Nephrol. 2007 Feb;18(2):539-50.

19.

Glomerular cell death and inflammation with high-protein diet and diabetes.

Meek RL, LeBoeuf RC, Saha SA, Alpers CE, Hudkins KL, Cooney SK, Anderberg RJ, Tuttle KR.

Nephrol Dial Transplant. 2013 Jul;28(7):1711-20. doi: 10.1093/ndt/gfs579.

20.

Vegfa protects the glomerular microvasculature in diabetes.

Sivaskandarajah GA, Jeansson M, Maezawa Y, Eremina V, Baelde HJ, Quaggin SE.

Diabetes. 2012 Nov;61(11):2958-66. doi: 10.2337/db11-1655.

Supplemental Content

Support Center